Clinical Trials Browser

Phase 2 × INDUSTRY × Melanoma, Cutaneous Malignant × Clear all

NCT03541148 2018-05-30

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

Phase 2 Completed

Melanoma, Cutaneous Malignant, Melanoma